Vincent C. Leeuwenburgh

Vincent C. Leeuwenburgh

Auto-generated profile, based on publicly available information

Vincent C. Leeuwenburgh

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
CUCarlos G. Urzúa-Traslaviña
Carlos G. Urzúa-Traslaviña
VLVincent C. Leeuwenburgh
Vincent C. Leeuwenburgh
ABArkajyoti Bhattacharya
Arkajyoti Bhattacharya
SLStefan Loipfinger
Stefan Loipfinger
MVMarcel A. T. M. van Vugt
Marcel A. T. M. van Vugt
RFRudolf S. N. Fehrmann
Rudolf S. N. Fehrmann
The interpretation of high throughput sequencing data is limited by our incomplete functional understanding of coding and non-coding transcripts. Reliably predicting the function of such transcripts can overcome this limitation. Here we report the use of a consensus independent component analysis and guilt-by-association approach to predict over 23,000 functional groups comprised of over 55,000 coding and non-coding transcripts using publicly available transcriptomic profiles. We show that, compared to using Principal Component Analysis, Independent Component Analysis-derived transcriptional components enable more confident functionality predictions, improve predictions when new members are added to the gene sets, and are less affected by gene multi-functionality. Predictions generated using human or mouse transcriptomic data are made available for exploration in a publicly available web portal.

1 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
VLVincent C. Leeuwenburgh
Vincent C. Leeuwenburgh
CUCarlos G. Urzúa-Traslaviña
Carlos G. Urzúa-Traslaviña
ABArkajyoti Bhattacharya
Arkajyoti Bhattacharya
MWMarthe Walvoort
Marthe Walvoort
MJMathilde Jalving
Mathilde Jalving
RFRudolf S. N. Fehrmann
Rudolf S. N. Fehrmann
Patient-derived expression profiles of cancers can provide insight into transcriptional changes that underlie reprogrammed metabolism in cancer. These profiles represent the average expression pattern of all heterogeneous tumor and non-tumor cells present in biopsies of tumor lesions. Therefore, subtle transcriptional footprints of metabolic processes can be concealed by other biological processes and experimental artifacts. We, therefore, performed consensus Independent Component Analyses (c-ICA) with 34,494 bulk expression profiles of patient-derived tumor biopsies, non-cancer tissues, and cell lines. c-ICA enabled us to create a transcriptional metabolic landscape in which many robust metabolic transcriptional components and their activation score in individual samples were defined. Here we demonstrate how this landscape can be used to explore associations between the metabolic transcriptome and drug sensitivities, patient outcomes, and the composition of the immune tumor microenvironment. The metabolic landscape can be explored at http://www.themetaboliclandscapeofcancer.com .